Pigmentation Disorders: Clinical Trials

700 trials for Pigmentation Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

339 completed, 155 unknown, 64 recruiting, 50 not yet recruiting. 291 Not applicable, 125 Phase 2, 64 Phase 4, 54 Phase 3, 44 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable291Completed 150, Unknown 73, Not yet recruiting 24, Recruiting 16, Terminated 12, Active not recruiting 8, Withdrawn 5, Enrolling by invitation 2, Suspended 1
Phase 2125Completed 55, Unknown 17, Terminated 15, Recruiting 13, Not yet recruiting 10, Active not recruiting 7, Withdrawn 6, Enrolling by invitation 1, Suspended 1
Phase 464Completed 26, Unknown 21, Not yet recruiting 4, Recruiting 4, Active not recruiting 3, Enrolling by invitation 2, Terminated 2, Withdrawn 2
Phase 354Completed 25, Unknown 8, Not yet recruiting 6, Recruiting 5, Active not recruiting 3, Terminated 3, Withdrawn 3, Suspended 1
Phase 144Completed 18, Unknown 7, Active not recruiting 5, Recruiting 5, Not yet recruiting 3, Terminated 3, Withdrawn 3
Early Phase 112Completed 5, Recruiting 2, Unknown 2, Enrolling by invitation 1, Not yet recruiting 1, Withdrawn 1

Follow Pigmentation Disorders: new trials by email Literature Review of Pigmentation Disorders trials Research Report on Pigmentation Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness and Safety of Cellbooster Glow in Healthy Subjects
Injectable - Wrinkle Appearance, Skin Hydration in Healthy Volunteers
Not applicableNot yet recruitingSuisselle602027-02-012026-11-10
Vitiligo Registry for Adults and Children in the UK
Dermatologic Disease, Vitiligo
Not yet recruitingThe Royal Wolverhampton Hospitals NHS Trust302026-12-152026-09-15
Two Trials to Evaluate TEV-53408 in Participants With Non-Segmental Vitiligo
TEV-53408 Dose A, TEV-53408 Dose B, Placebo - Vitiligo
Phase 2 / Phase 3Not yet recruitingTeva Branded Pharmaceutical Products R&D LLC10202026-11-162026-11-05
Baseline Dermoscopic Vascular Score and Response to Oral Tranexamic Acid in Facial Melasma
Tranexamic acid, Standardised sunscreen and emollient - Melasma
Phase 4Not yet recruitingAllied Hospital Faisalabad1282026-11-012026-10-19
COMPARISON OF TOPICAL VITAMIN C VS NIACINAMIDE IN TREATMENT OF MELASMA
Ascorbic acid, niacinamide - Melasma
Not applicableNot yet recruitingPak Emirates Military Hospital1002026-11-012026-10-22
VItiligo RegisTry adUlts And chiLdren-France
Vitiligo treatments in routine clinical practice - Vitiligo
Not yet recruitingAssistance Publique - Hôpitaux de Paris1002026-11-012026-11-10
A Clinical Trial of Multiple Doses of GR2301 Injection in Participants With Vitiligo.
GR2301 injection, Placebo - Vitiligo
Phase 2Not yet recruitingGenrix (Shanghai) Biopharmaceutical Co., Ltd.1202026-11-012026-11-10
Chinese Multicenter Registry for Peutz-Jeghers Syndrome
Peutz-Jeghers Syndrome
RecruitingFirst People's Hospital of Hangzhou10002026-11-012026-11-12
Microneedling-Assisted Metformin, Tranexamic Acid, and Modified Kligman's Formula for Melasma
Metformin 30% Topical Lotion, Tranexamic Acid 0.5% Topical Solution, Modified Kligman's Formula - Melasma (Facial Melasma)
Phase 4Enrolling by invitationSameh Sarsik802026-10-252026-10-27
New Treatment in Melasma
Tranexamic Acid - topical, Microneedling with Topical Tranexamic acid, Modified Kligman's Formula - Female, With
Not applicableNot yet recruitingSohag University752026-10-182026-10-21
Efficacy and Safety of Triple-Combination Cream Plus Microneedling Along With Tranexamic Acid Versus Platelet-Rich Plasma in the Treatment of Moderate-to-Severe Melasma: A Randomized Comparative Study
Group B (Triple Combination Cream + Microneedling + Platelet-Rich Plasma) - Melasma (Facial Melasma)
Phase 4Active not recruitingBangladesh Medical University602026-10-132026-10-23
Local Warming to Improve Pulse Oximetry Accuracy in Critically Ill Patients
Protocolized Local Warming - Critical Illness, Low Peripheral Perfusion
Not applicableNot yet recruitingVastra Gotaland Region2402026-10-012026-09-25
An Observational Study of Patients With Dermatologic Disease
Vitiligo, Atopic Dermatitis
Not yet recruitingTarget PharmaSolutions, Inc.20000002026-09-012026-09-10
Mitochondrial Network Modulation Approach Using Hyperbaric Oxygen (HBO) Therapy and Nb-UVB for Treating Vitiligo
OXYGENE MEDICINAL LIQUIDE AIR PRODUCTS MEDICAL - Vitiligo Vulgaris
Phase 2 / Phase 3Not yet recruitingCentre Hospitalier Universitaire de Nice52026-09-012026-06-05
Foam Sclerotherapy With or Without Transdermal Laser for Reticular Veins and Telangiectasias
Polidocanol foam sclerotherapy, Transdermal 1064 nm Nd:YAG Laser - Telangiectasias, Reticular Veins
Phase 4RecruitingUniversity of Sao Paulo702026-09-012026-11-06
Evaluating a Brightening Serum for Post-Inflammatory Hyperpigmentation
Vinoperfect brightening serum - Post-inflammatory Hyperpigmentation, Post-acne Hyperpigmentation
Not applicableNot yet recruitingWeill Medical College of Cornell University202026-09-012026-10-30
Fractional CO2 Laser vs Dermabrasion With 5-Fluorouracil for Acquired Leukoderma
Fractional CO2 Laser, Dermabrasion, 5-Fluorouracil - Leukoderma, Hypopigmentation
Not applicableNot yet recruitingAl-Azhar University162026-08-262026-09-24
PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents
Vitiligo
RecruitingCorEvitas25002026-08-212026-08-26
Topical Metformin Versus Triple Regimen for Epidermal Melasma
Topical 30% metformin cream, Topical Triple Regimen - Epidermal Melasma, Facial Hyperpigmentation
Phase 2Not yet recruitingCombined Military Hospital, Pakistan1042026-08-152026-08-21
Clinical Efficacy and Mechanisms of a Topical Azone-Tranexamic Acid-Aloe Polysaccharide Gel in the Treatment of Melasma
Ligustrazine - tranexamic acid - aloe polysaccharide composite gel - Melasma, Treatment of Stable Melasma
Not applicableNot yet recruitingThe First Affiliated Hospital of Xinxiang Medical College102026-08-122026-04-14

Showing 20 of 700. Sign in to see all of them.

Narrower conditions

Vitiligo (297)  ·  Melanosis (170)  ·  Hyperpigmentation (106)  ·  Peutz-Jeghers Syndrome (22)  ·  Psoriasis (20)  ·  Skin Diseases (20)  ·  Acne Vulgaris (19)  ·  Dermatitis, Atopic (19)  ·  Acanthosis Nigricans (18)  ·  Piebaldism (18)  ·  Albinism (17)  ·  Alopecia Areata (16)  ·  Lentigo (13)  ·  Xeroderma Pigmentosum (12)

Broader conditions

Skin and Connective Tissue Diseases (699)  ·  Skin Diseases (680)  ·  Hypopigmentation (337)  ·  Hyperpigmentation (192)  ·  Pathological Conditions, Signs and Symptoms (127)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (117)  ·  Genetic Diseases, Inborn (109)  ·  Pathologic Processes (96)  ·  Nutritional and Metabolic Diseases (90)  ·  Skin Diseases, Genetic (86)  ·  Metabolic Diseases (84)  ·  Neoplasms (70)  ·  Melanosis (52)  ·  Eye Diseases, Hereditary (51)

Interventions

Tranexamic Acid (26)  ·  hydroquinone (20)  ·  Percutaneous Collagen Induction (18)  ·  Phototherapy (13)  ·  Tacrolimus (13)  ·  Tretinoin (12)  ·  Metformin (10)  ·  Lasers, Excimer (9)  ·  ruxolitinib (9)  ·  Blood Specimen Collection (8)  ·  Lasers (7)  ·  Ointments (7)  ·  Therapeutics (7)  ·  afamelanotide (7)  ·  Fluorouracil (6)

Sponsors

Assiut University (27)  ·  Cairo University (26)  ·  Centre Hospitalier Universitaire de Nice (24)  ·  Cosmetique Active International (13)  ·  Henry Ford Health System (12)  ·  Sohag University (12)  ·  University Hospital, Bordeaux (11)  ·  Cryonove Pharma (9)  ·  Universidad Autonoma de San Luis Potosí (8)  ·  Incyte Corporation (7)  ·  National Human Genome Research Institute (NHGRI) (7)  ·  Xijing Hospital (7)  ·  Al-Azhar University (6)  ·  Combined Military Hospital Abbottabad (6)  ·  Kasr El Aini Hospital (6)

Countries

United States (213)  ·  France (67)  ·  Egypt (57)  ·  China (51)  ·  Pakistan (31)  ·  Canada (26)  ·  Brazil (21)  ·  Netherlands (18)  ·  Indonesia (15)  ·  Italy (15)  ·  Mexico (15)  ·  United Kingdom (15)  ·  South Korea (14)  ·  Germany (13)  ·  India (12)

Top investigators

Passeron Thierry, PhD (7)  ·  Murad Alam, MD (5)  ·  Andrew McGovern, MD (4)  ·  Bertha Torres-Alvarez, MD (4)  ·  Harvey Lui, MD, FRCPC (4)  ·  Juan P Castanedo-Cazares, MD (4)  ·  Kathleen Butler, MD (4)  ·  Thierry Passeron, PhD (4)  ·  Iltefat H Hamzavi, MD (3)  ·  Iltefat Hamzavi, MD (3)  ·  Jeffrey Kenkel, MD (3)  ·  Wendy J Introne, M.D. (3)

Results publications

PMID 25184917, PMID 41125994, PMID 20364383, PMID 23919018, PMID 25068546, PMID 25596811, PMID 28726212, PMID 29445374, PMID 30369044, PMID 30601885, PMID 32443482, PMID 36260792, PMID 40156697, PMID 10803620, PMID 11096382, PMID 12410698, PMID 12516826, PMID 15149497, PMID 15888156, PMID 16631967, PMID 17199653, PMID 17659004, PMID 17875874, PMID 18021205, PMID 18419607, PMID 19043850, PMID 19067714, PMID 19481375, PMID 19627411, PMID 19787413, PMID 20083690, PMID 20197747, PMID 20398959, PMID 20413357, PMID 20458532, PMID 20514787, PMID 20961233, PMID 20966063, PMID 20981308, PMID 21275943, PMID 21384391, PMID 21406109, PMID 21451378, PMID 21920241, PMID 21920242, PMID 22154461, PMID 22676819, PMID 22892471, PMID 23003920, PMID 23093467

NIH funding

2023 (4), 2025 (4), 2019 (3), 2018 (2), 2009 (1), 2016 (1), M01RR006022 (1), P30CA015704 (1), R01CA176828 (1), R33AR077495 (1), U01CA210170 (1), U54HL127672 (1), UM1CA154967 (1)